NCT04072016 - Study of the Beacon Aqueous Microshunt in Patients With Refractory Glaucoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

May 16, 2022

Study Completion Date

November 30, 2022

Conditions

Glaucoma

Interventions

DEVICE

Beacon Aqueous Microshunt

The Beacon Aqueous Microshunt (BAM) is an implantable device intended to reduce intraocular pressure (IOP) in patients with refractory glaucoma by shunting aqueous humor from the anterior chamber to the surface of the eye.

Trial Locations (4)

45405

iWorks Laser and Vision Center, Dayton

55431

Minnesota Eye Consultants, Bloomington

81501

Icon Eye Care, Grand Junction

J7H 0E8

Institut de l'oeil des Laurentides, Boisbriand